Category: T
Royal Mail Tracked 24 (Signed For)
Royal Mail Special Delivery Guaranteed by 1pm
| Category | POM-V |
| Temperature | Ambient |
| MA/VM/EU No: | 42058/4154 |
| Species |
|
| VMD Link | https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_139402.PDF |
| NOAH Link | |
| Dosage | HORSE For analgesia Dose rate: 5 ml/500 kg (equivalent to 0.1 mg butorphanol/kg) bodyweight, by intravenous injection. The dose may be repeated as required. Analgesic effects are seen within 15 minutes of injection. Torbugesic for Equine Analgesia – (IV) Weight of Horse - kgs Dose of Torbugesic (10 mg/ml) - mls 50 0.5 100 1.0 150 1.5 200 2.0 250 2.5 300 3.0 350 3.5 400 4.0 450 4.5 500 5.0 550 5.5 For sedation in combination with detomidine hydrochloride A dose rate of 0.1 ml Domosedan™/100 kg (equivalent to 0.012 mg/kg detomidine hydrochlorideg) should be given intravenously followed within 5 minutes by a dose rate of 0.025 mg/kg butorphanol intravenously (equivalent to 0.25 ml Torbugesic Injection/100 kg). Clinical experience has shown that a total dose 0.5 ml Domosedan and 1.0 ml Torbugesic Injection affords effective, safe sedation in horses above 200 kg bodyweight. Torbugesic and detomidine Combination for Equine Sedation – (IV) Weight of Horse – kgs:— Dose of detomidine (10 mg/ml) – mls:— Dose of Torbugesic (10 mg/ml) – mls:— 50 0.05 0.10 100 0.10 0.25 150 0.20 0.4 200 0.25 0.5 250 0.50 1.0 300 0.50 1.0 350 0.50 1.0 400 0.50 1.0 450 0.50 1.0 500 0.50 1.0 550 0.50 1.0 NB. Detomidine should be administered up to 5 minutes before the Torbugesic dose For sedation in combination with romifidine A dose of 0.4–1.2 ml Sedivet™/100 kg bodyweight (equivalent to 40–120 μg romifidine/kg) followed by 0.2 ml Torbugesic Injection/100 kg bodyweight (equivalent to 20 μg butorphanol/kg) should be administered intravenously. Torbugesic and romifidine Combination for Equine Sedation – (IV) Weight of Horse – kgs:— * Dose of romifidine (10 mg/ml) – mls:— Dose of Torbugesic (10 mg/ml) – mls:— 50 0.3 0.1 100 0.6 0.2 150 0.9 0.3 200 1.2 0.4 250 1.5 0.5 300 1.8 0.6 350 2.1 0.7 400 2.4 0.8 450 2.7 0.9 500 3.0 1.0 550 3.3 1.1 * Above example based on a dose rate of 60 μg romifidine/kg bodyweight. NB. Romifidine should be administered up to 5 minutes before the Torbugesic dose. DOG For analgesia Administer by intravenous, intramuscular or subcutaneous injection routes using aseptic technique. Rapid IV injection should be avoided. Dose rate 0.2–0.3 ml/10 kg (equivalent to 0.2–0.3 mg butorphanol/kg) bodyweight. Torbugesic Injection should be administered before terminating anaesthesia to provide analgesia in the recovery phase. Analgesic effects are seen within 15 minutes. For continuous analgesia the dose may be repeated as required. Torbugesic for Canine Analgesia – (IV, IM or SC) Weight of Dog – kgs:— *Dose of Torbugesic (10 mg/ml) – mls:— 1 0.03 3 0.07 5 0.1 10 0.3 15 0.4 20 0.5 25 0.6 30 0.8 40 1.0 * Based on a mean dose rate of 0.25 mg butorphanol/kg. For sedation in combination with medetomidine hydrochloride Torbugesic Injection should be administered at 0.1 ml/10 kg bodyweight (equivalent to 0.1 mg butorphanol/kg) together with 0.1–0.25 ml Domitor™/10 kg bodyweight (equivalent to 10–25 μg medetomidine/kg) depending on degree of sedation required, both by intramuscular or intravenous injection. Domitor and Torbugesic may be combined and administered in the same syringe. However, the vials should have separate needles inserted for withdrawal to minimise the risk of cross contamination. Allow 20 minutes for profound sedation to develop before commencing the procedure. Reversal with 0.1–0.25 ml Antisedan™/10 kg bodyweight (equivalent to 50–125 μg atipamezole/kg) results in sternal recumbency approximately 5 minutes later and standing approximately a further 2 minutes later. Torbugesic and medetomidine Combination for Canine Sedation – (IM or IV) For sedation and as a premedicant to barbiturate anaesthesia Weight of Dog – kgs:— *Dose of Torbugesic (10 mg/ml) – mls:— *Dose of medetomidine (1 mg/ml) – mls:— 1 0.01 0.01 3 0.03 0.03 5 0.05 0.05 10 0.10 0.10 15 0.15 0.15 20 0.20 0.20 25 0.25 0.25 30 0.30 0.30 40 0.40 0.40 * Based on a dose rate of 0.1 mg butorphanol/kg and 10 μg medetomidine/kg. Torbugesic and medetomidine Combination for Canine Sedation – (IM or IV) For profound sedation and as a premedicant to ketamine anaesthesia Weight of Dog – kgs:— Dose of *Torbugesic (10 mg/ml) – mls:— Dose of *medetomidine (1 mg/ml) – mls:— 1 0.01 0.03 3 0.03 0.08 5 0.05 0.13 10 0.10 0.25 15 0.15 0.38 20 0.20 0.50 25 0.25 0.63 30 0.30 0.75 40 0.40 1.00 * Based on a dose rate of 0.1 mg butorphanol/kg and 25 μg medetomidine/kg. For use as a pre-anaesthetic Used as a pre-anaesthetic, the Torbugesic Injection dose should be reduced to 0.1-0.2 ml/10 kg (0.1-0.2 mg butorphanol/kg), given 15 minutes prior to induction. Torbugesic for Canine Analgesia Pre-Anaesthetic – (IV, IM, or SC) Weight of Dog – kgs:— *Dose of Torbugesic (10 mg/ml) – mls:— 1 0.01 3 0.03 5 0.05 10 0.10 15 0.15 20 0.20 25 0.25 30 0.30 40 0.40 *Pre-anaesthetic doses: based on dose rate of 0.10 mg butorphanol/kg. For use as a pre-anaesthetic combination with acepromazine Torbugesic Injection should be administered at 0.1 ml/10 kg bodyweight (equivalent to 0.1 mg butorphanol/kg) together with 0.1 ml of 2 mg/ml acepromazine/10 kg bodyweight (equivalent to 0.02 mg acepromazine/kg) by intramuscular or intravenous injection. Torbugesic and acepromazine may be combined and administered in the same syringe. However the vials should have separate needles inserted for withdrawal to minimise the risk of cross contamination. Allow at least 20 minutes for onset of action but the time between premedication and induction is flexible from 20-120 minutes. The dose of butorphanol may be increased to 0.2 mg/kg (equivalent to 0.2 ml Torbugesic Injection/10 kg bodyweight) if the animal is already experiencing pain before the procedure commences, or if a higher plane of analgesia is required during surgery. Torbugesic and acepromazine Combination for Canine Analgesia and Sedation Pre Anaesthetic (IM or IV) Weight of dog - kgs:- Dose of *Torbugesic (10 mg/ml) - mls:- Dose of **acepromazine (2 mg/ml) - mls:- 1 0.01 0.01 3 0.03 0.03 5 0.05 0.05 10 0.1 0.1 15 0.15 0.15 20 0.2 0.2 25 0.25 0.25 30 0.3 0.3 40 0.4 0.4 * Based on a dose rate of 0.1 mg butorphanol/kg bodyweight. ** Based on a dose rate of 0.02 mg acepromazine/kg bodyweight. For anaesthesia in combination with medetomidine and ketamine Administer Torbugesic Injection at 0.1 ml/10 kg (equivalent to 0.1 mg butorphanol/kg) and Domitor at 0.25 ml/10 kg (equivalent to 25 μg medetomidine/kg) by intramuscular injection. Domitor and Torbugesic may be combined and administered in the same syringe. However, the vials should have separate needles inserted for withdrawal to minimise the risk of cross-contamination. Dogs become recumbent in approximately 6 minutes and lose their pedal reflex in approximately 14 minutes. Ketamine (100 mg/ml) should be administered 15 minutes following the first injection at 0.5 ml/10 kg (equivalent to 5 mg ketamine/kg) by intramuscular injection. The pedal reflex returns approximately 53 minutes following administration of the ketamine injection. Sternal recumbency is attained approximately 35 minutes later followed by standing a further 36 minutes later. Torbugesic, medetomidine and ketamine for Canine Anaesthesia – (IM) Weight of Dog – kgs:— Dose of *Torbugesic (10 mg/ml) – mls:— Dose of **medetomidine (1 mg/ml) – mls:— 1 0.01 0.03 3 0.03 0.08 5 0.05 0.13 10 0.10 0.25 15 0.15 0.38 20 0.20 0.50 25 0.25 0.63 30 0.30 0.75 40 0.40 1.00 ADMINISTER TORBUGESIC & MEDETOMIDINE BY INTRAMUSCULAR INJECTION AT THE ABOVE DOSE RATES WAIT 15 MINUTES BEFORE ADMINISTERING THE KETAMINE BY INTRAMUSCULAR INJECTION AT THE DOSE RATES BELOW Weight of Dog - kgs: Dose of ***ketamine (100 mg/ml) - mls: 1 0.05 3 0.15 5 0.25 10 0.50 15 0.75 20 1.00 25 1.25 30 1.50 40 2.00 * Based on a dose rate of 0.1 mg butorphanol/kg. ** Based on a dose rate of 25 μg medetomidine/kg. *** Based on a dose rate of 5 mg ketamine/kg. NB: It is NOT advisable to reverse this combination in the dog with atipamezole. CAT For pre-operative analgesia 0.2 ml Torbugesic injection/ 5 kg bodyweight (equivalent to 0.4 mg butorphanol/kg), should be administered either by subcutaneous or intramuscular injection. Clinical studies have shown that administering the butorphanol dose 5 minutes prior to induction with either acepromazine/ketamine or xylazine/ketamine given intramuscularly will provide analgesia when surgery commences. The arousal time will not be significantly altered. With intravenous induction agents, butorphanol should be administered 15–30 minutes prior to administration of the anaesthetic. For post-operative analgesia 0.2 ml Torbugesic Injection/ 5 kg bodyweight (equivalent to 0.4 mg butorphanol/kg), should be administered by either subcutaneous or intramuscular injection 15 minutes prior to recovery. Alternatively, 0.05 ml Torbugesic Injection/5 kg (equivalent to 0.1 mg butorphanol/kg), by intravenous injection can be used. Torbugesic for Feline Analgesia Body weight – kgs:— Dose (ml) *IV Torbugesic Injection™ (10 mg/ml) Dose (ml)**IM or SC Torbugesic Injection (10 mg/ml) 1 0.01 0.04 1.5 0.02 0.06 2.0 0.02 0.08 2.5 0.03 0.10 3.0 0.03 0.12 3.5 0.04 0.14 4.0 0.04 0.16 4.5 0.05 0.18 5.0 0.05 0.20 * Based on a mean dose rate of 0.1 mg butorphanol/kg. **Based on a mean dose rate of 0.4 mg butorphanol/kg. For sedation in combination with medetomidine hydrochloride Torbugesic Injection should be administered at 0.2 ml/5 kg bodyweight (equivalent to 0.4 mg butorphanol/kg) together with 0.25 ml Domitor/5 kg bodyweight (equivalent to 50 μg medetomidine/kg) both by either intramuscular or subcutaneous injection. Domitor and Torbugesic may be combined and administered in the same syringe. However, the vials should have separate needles inserted for withdrawal to minimise the risk of cross contamination. Local anaesthetic infiltration should be used for wound suturing. Reversal with 0.125 ml Antisedan/5 kg bodyweight (equivalent to 125 μg atipamezole/kg) results in sternal recumbency approximately 4 minutes later and standing 1 minute later. Torbugesic and medetomidine Combination for Feline Sedation – (IM or SC) Weight of Cat – kgs:— Dose of *Torbugesic (10 mg/ml) – mls:— Dose of **medetomidine (1 mg/ml) – mls:— 1 0.04 0.05 1.5 0.06 0.08 2 0.08 0.10 2.5 0.10 0.13 3 0.12 0.15 3.5 0.14 0.18 4 0.16 0.20 4.5 0.18 0.23 5 0.20 0.25 *Based on a dose rate of 0.4 mg butorphanol/kg. **Based on a dose rate of 50 μg medetomidine/kg. For anaesthesia in combination with medetomidine and ketamine (a) Intramuscular Administer Torbugesic Injection at 0.2 ml/5 kg (equivalent to 0.4 mg butorphanol/kg), 0.4 ml Domitor/5 kg (equivalent to 80 μg medetomidine/kg) and ketamine (100mg/ml) at 0.25 ml/5 kg (equivalent to 5 mg ketamine/kg). Domitor, Torbugesic and Ketaset may be combined and administered in the same syringe. However, the vials should have separate needles inserted for withdrawal to minimise the risk of cross-contamination. Cats become recumbent in 2–3 minutes following injection. Loss of the pedal reflex occurs 3 minutes post-injection. Torbugesic, medetomidine and ketamine Combination for Feline Anaesthesia – (IM) Weight of Cat – kgs: Dose of *Torbugesic (10 mg/ml) – mls: Dose of **medetomidine (1 mg/ml) – mls: Dose of ***ketamine (100 mg/ml) – mls: 1.5 0.06 0.12 0.08 2 0.08 0.16 0.10 2.5 0.10 0.20 0.13 3 0.12 0.24 0.15 3.5 0.14 0.28 0.18 4 0.16 0.32 0.20 4.5 0.18 0.36 0.23 5 0.20 0.40 0.25 * Based on a dose rate of 0.4 mg butorphanol/kg. ** Based on a dose rate of 80 μg medetomidine/kg. *** Based on a dose rate of 5 mg ketamine/kg. Reversal with 0.2 ml Antisedan/5 kg (equivalent to 200 μg atipamezole/kg) results in return of the pedal reflex 2 minutes later, sternal recumbency 6 minutes later and standing 31 minutes later. (b) Intravenous Administer Torbugesic Injection at 0.05 ml/5 kg bodyweight (equivalent to 0.1 mg butorphanol/kg), 0.2 ml Domitor/5 kg bodyweight (equivalent to 40 μg medetomidine/kg) and ketamine (100 mg/ml), depending on depth of anaesthesia required, at a dose rate of 0.06–0.13 ml/5 kg (equivalent to 1.25–2.5 mg ketamine/kg) by intravenous injection. Domitor and Torbugesic and Ketaset may be combined and administered in the same syringe. However, the vials should have separate needles inserted for withdrawal to minimise the risk of cross-contamination. Approximate time scales when using the triple combination intravenously. *Ketamine dose mg/kg 1.25 2.5 Time to recumbency 32 secs 22 secs Time to loss of pedal reflex 62 secs 39 secs Time to return of pedal reflex 26 mins 28 mins Time to sternal recumbency 54 mins 62 mins Time to standing 74 mins 83 mins *In conjunction with butorphanol at 0.1mg/kg and medetomidine at 40 μg/kg. Torbugesic, medetomidine and ketamine for Feline Anaesthesia – (IV) Dosage chart for 2.5 mg ketamine/kg (duration of anaesthesia approximately 28 minutes) Weight of Cat – kgs: Dose of *Torbugesic (10 mg/ml) – mls: Dose of **medetomidine (1 mg/ml) – mls: Dose of ***ketamine (100 mg/ml) – mls: 1.5 0.02 0.06 0.04 2 0.02 0.08 0.05 2.5 0.03 0.10 0.06 3 0.03 0.12 0.08 3.5 0.04 0.14 0.09 4 0.04 0.16 0.10 4.5 0.05 0.18 0.11 5 0.05 0.20 0.13 * Based on a dose rate of 0.1 mg butorphanol/kg bodyweight. ** Based on a dose rate of 40 μg medetomidine/kg bodyweight. *** Based on a dose rate of 2.5 mg ketamine/kg bodyweight. Reversal with 0.1 ml Antisedan/5 kg (equivalent to 100 μg atipamezole/kg) results in return of the pedal reflex 4 minutes later, sternal recumbency 7 minutes later and standing 18 minutes later. |
| Withdrawals | Before using any combinations consult the contra-indications and warnings that appear on the other products' data sheets. HORSE Withdrawal Period: Meat & Offal: Zero days. Torbugesic Do not use in horses with a history of liver disease. The most commonly observed side-effect is slight ataxia which may persist for 3–10 minutes. Mild sedation may occur in approximately 15% of horses. Torbugesic/detomidine hydrochloride combination Do not use in horses with a history of liver disease. The combination should not be used in pregnant animals nor in animals suffering from colic. Routine cardiac auscultation should be performed prior to use of this combination. Do not use the combination in horses with a pre-existing cardiac dysrhythmia or bradycardia. Mild to severe ataxia may be encountered but clinical studies have shown that horses are unlikely to collapse. Normal precautions should be observed to prevent patient self-injury. Torbugesic/romifidine combination Do not use in horses with a history of liver disease. The combination should not be used during the last month of pregnancy. DOG If respiratory depression occurs, naloxone may be used as an antidote. Do not use in dogs with a history of liver disease. Transient ataxia, anorexia and diarrhoea have been reported as occurring rarely. When using Torbugesic as a pre-anaesthetic the use of an anti-cholinergic, such as atropine will protect the heart against possible narcotic-induced bradycardia. When administering as an intravenous injection do not inject as a bolus. CAT If respiratory depression occurs, naloxone may be used as an antidote. Do not use in cats with a history of liver disease. Cats should be weighed to ensure that the correct dose is calculated. Use of either insulin syringes or 1 ml graduated syringes is recommended to ensure accurate dosing. Marked sedation does not occur in cats when Torbugesic Injection is used as a sole agent. Mydriasis is likely to occur. Operator warning Butorphanol has opioid-like activity. Precautions should be taken to avoid accidental injection/self-injection with this potent drug. If accidental self-injection occurs, seek immediate medical attention showing a copy of product literature. Do not drive. The effects of butorphanol include sedation, dizziness and confusion. Effects can be reversed with an opioid antagonist. Wash splashes from skin and eyes immediately. |
Animally Vet Supplies is the trading name of Veterinary Meds Online Ltd.
Company No. 12665548 | VMR No. 7386568 | Copyright 2022© All rights Reserved
